131 related articles for article (PubMed ID: 32366791)
1. Differences in 18F-FDG Uptake and Expression of Glucose Transporter Between 2 Distinct Subtypes of Mass-Forming Intrahepatic Cholangiocarcinomas.
Kozaka K; Kobayashi S; Takamura H; Sato Y; Kitao A; Inoue D; Yoneda N; Tajima H; Kinuya S; Harada K; Ohta T; Koda W; Matsui O; Gabata T
Clin Nucl Med; 2020 Jun; 45(6):e267-e273. PubMed ID: 32366791
[TBL] [Abstract][Full Text] [Related]
2. Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography.
Paudyal B; Oriuchi N; Paudyal P; Higuchi T; Nakajima T; Endo K
Cancer Sci; 2008 Feb; 99(2):260-6. PubMed ID: 18271924
[TBL] [Abstract][Full Text] [Related]
3. Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.
Lee JD; Yang WI; Park YN; Kim KS; Choi JS; Yun M; Ko D; Kim TS; Cho AE; Kim HM; Han KH; Im SS; Ahn YH; Choi CW; Park JH
J Nucl Med; 2005 Oct; 46(10):1753-9. PubMed ID: 16204727
[TBL] [Abstract][Full Text] [Related]
4. Differences on metabolic behavior between intra and extrahepatic cholangiocarcinomas at
Sabaté-Llobera A; Gràcia-Sánchez L; Reynés-Llompart G; Ramos E; Lladó L; Robles J; Serrano T; Mestres-Martí J; Gámez-Cenzano C
Clin Transl Oncol; 2019 Mar; 21(3):324-333. PubMed ID: 30022384
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.
Moon CM; Bang S; Chung JB; Park SW; Song SY; Yun M; Lee JD
J Gastroenterol Hepatol; 2008 May; 23(5):759-65. PubMed ID: 17931372
[TBL] [Abstract][Full Text] [Related]
6. Relationship between 18-F-fluoro-deoxy-D-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma.
Suzuki H; Komuta M; Bolog A; Yokobori T; Wada S; Araki K; Kubo N; Watanabe A; Tsukagoshi M; Kuwano H
Dig Liver Dis; 2015 Jul; 47(7):590-6. PubMed ID: 25912843
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the roles of glucose transporter 1 and hexokinase 2 in the metabolism of glucose by extrahepatic bile duct cancer cells.
Yoon SO; Jeon TJ; Park JS; Ryu YH; Lee JH; Yoo JS; Kim JK; Yoon DS; Oh EJ
Clin Nucl Med; 2015 Mar; 40(3):e178-82. PubMed ID: 25608150
[TBL] [Abstract][Full Text] [Related]
8. Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by
Ikeno Y; Seo S; Iwaisako K; Yoh T; Nakamoto Y; Fuji H; Taura K; Okajima H; Kaido T; Sakaguchi S; Uemoto S
J Transl Med; 2018 Apr; 16(1):95. PubMed ID: 29642912
[TBL] [Abstract][Full Text] [Related]
9. Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer.
Park MS; Lee SM
Anticancer Res; 2014 May; 34(5):2551-4. PubMed ID: 24778075
[TBL] [Abstract][Full Text] [Related]
10. Reappraisal of Prognostic Impact of Tumor SUVmax by
Yoh T; Seo S; Morino K; Fuji H; Ikeno Y; Ishii T; Taura K; Nakamoto Y; Higashi T; Kaido T; Uemoto S
World J Surg; 2019 May; 43(5):1323-1331. PubMed ID: 30680501
[TBL] [Abstract][Full Text] [Related]
11. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
Paudyal B; Paudyal P; Oriuchi N; Tsushima Y; Nakajima T; Endo K
Int J Oncol; 2008 Nov; 33(5):1047-54. PubMed ID: 18949368
[TBL] [Abstract][Full Text] [Related]
12. Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma.
Jiang L; Tan H; Panje CM; Yu H; Xiu Y; Shi H
Clin Nucl Med; 2016 Jan; 41(1):1-7. PubMed ID: 26402131
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.
Kim YJ; Yun M; Lee WJ; Kim KS; Lee JD
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1467-72. PubMed ID: 14579085
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Higuchi T; Miyakubo M; Ishikita T; Nakajima T; Endo K
Ann Nucl Med; 2008 Jan; 22(1):83-6. PubMed ID: 18250992
[TBL] [Abstract][Full Text] [Related]
15. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
[TBL] [Abstract][Full Text] [Related]
16. Relationship between clinicopathological factors and fluorine-18-fluorodeoxyglucose uptake in patients with papillary thyroid cancer.
Kaida H; Hiromatsu Y; Kurata S; Kawahara A; Hattori S; Taira T; Kobayashi M; Uchida M; Yamada K; Mihashi H; Umeno H; Kage M; Nakashima T; Hayabuchi N; Ishibashi M
Nucl Med Commun; 2011 Aug; 32(8):690-8. PubMed ID: 21606885
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of Preoperative
Ikeno Y; Seo S; Yamamoto G; Nakamoto Y; Uemoto Y; Fuji H; Yoshino K; Yoh T; Taura K; Uemoto S
Anticancer Res; 2018 Jun; 38(6):3677-3682. PubMed ID: 29848727
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between TNM staging of primary cholangiocarcinoma and the maximum standard uptake value of (18)F-2-deoxy-D-glucose positron emission tomography with computerized tomography].
Wang ZF; Lan XL; Xiao YR; Liu JP; Ji JS
Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(39):3104-3107. PubMed ID: 29081157
[No Abstract] [Full Text] [Related]
20. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.
Park SG; Lee JH; Lee WA; Han KM
Nucl Med Biol; 2012 Nov; 39(8):1167-72. PubMed ID: 22901702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
